Validation of a Prognostic Model and the Impact of Mutations in Patients With Lower-Risk Myelodysplastic Syndromes

PURPOSE: A subset of patients with myelodysplastic syndromes (MDS) who are predicted to have lower-risk disease as defined by the International Prognostic Scoring System (IPSS) demonstrate more aggressive disease and shorter overall survival than expected. The identification of patients with greater...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Bejar, Rafael, Stevenson, Kristen E., Caughey, Bennett A., Abdel-Wahab, Omar, Steensma, David P., Galili, Naomi, Raza, Azra, Kantarjian, Hagop, Levine, Ross L., Neuberg, Donna, Garcia-Manero, Guillermo, Ebert, Benjamin L.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society of Clinical Oncology 2012
Gaiak:
ORIGINAL REPORTS
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3438234/
https://ncbi.nlm.nih.gov/pubmed/22869879
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2011.40.7379
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak